School of Medicine

Showing 191-200 of 539 Results

• 

  Azusa Terasaki

  Postdoctoral Scholar, Pathology
  

  BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
  Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
  Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes.

  • Contact Info

  • Other Names:

    Azusa Murayama Terasaki
• 

  Rika Terashima

  Affiliate, Med/Quantitative Sciences Unit
  
• 

  Itamar Terem

  Casual - Non-Exempt, Adult Neurology
  
• 

  Abdullah Sulieman Terkawi, MD, MS

  Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
  
• 

  Aslihan Terzi

  Member, Maternal & Child Health Research Institute (MCHRI)
  
• Ezra Tesfay

  Administrative Associate, Emergency Medicine
  
• Alayet Tesfaye

  Sr. HR Administrator, Medicine
  
• 

  Nahom Worku Teshager

  Affiliate, Medicine - Primary Care and Population Health
  
• 

  Ana Tesi-Rocha, MD

  Clinical Professor, Pediatric Neurology
  Clinical Professor (By courtesy), Pediatrics
  
• 

  Stefano Testa, MD

  Instructor, Medicine - Oncology
  

  BioDr. Stefano Testa is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
  
  Dr. Testa specializes in treating patients with sarcomas and other solid tumors using cellular therapy approaches. He has expertise in adoptive T-cell therapies, including chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies.
  
  As a physician-scientist, Dr. Testa focuses on developing next-generation cellular therapies for solid tumors, particularly sarcomas. His research goal is to identify targets for adoptive T-cell therapies in solid tumors, including soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
  
  Dr. Testa has authored numerous peer-reviewed publications in leading medical journals, including Immunity, Cancer Discovery, JAMA Network Open, Genome Medicine, and Biomacromolecules. He has presented his research at national and international scientific meetings, including the Connective Tissue Oncology Society Annual Meeting and the Society for Immunotherapy of Cancer Annual Meeting.
  
  Dr. Testa is a member of the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), the American Society of Hematology (ASH), and the Society for Immunotherapy of Cancer (SITC).